Clinical Trials Browser

Phase 2 × Melanoma × Gemcitabine × Clear all

NCT05031494 2025-01-06

A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

Phase 2 Completed

Melanoma